@article{article, title  = {{Real-world (rw) first-line (1L) treatment (tx) patterns and overall survival (OS) in patients (pts) with locally advanced/metastatic urothelial carcinoma (la/mUC) and frailty or comorbidities.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{https://doi.org/10.1200/jco.2026.44.7_suppl.666 }},

 year = {{2026}},

 month = {{3}},

 author = {{Grande E and Bamias A and de Wit R and Hussain SA and Thibault C and Kearney M and Hoffman J and Morris V and Chen L and Roos J and Hankinson E et al}},

 doi = {{10.1200/jco.2026.44.7_suppl.666}},

 volume = {{44}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{7_suppl}},

 pages = {{666-666}},

 note = {{Accessed on 2026/04/02}}}